Contemporary Treatment of Locally Advanced Oral Cancer

被引:43
作者
Kim, David [1 ]
Li, Ryan [1 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, 3181 SW Sam Jackson Pk Rd,PV01, Portland, OR 97239 USA
关键词
Oral cavity squamous cell carcinoma; Treatment; Primary chemoradiotherapy; Immunotherapy; Neoadjuvant therapy; Outcome; SQUAMOUS-CELL CARCINOMA; PHASE-III TRIAL; CONCURRENT CHEMORADIOTHERAPY; ADJUVANT RADIOTHERAPY; NECK-CANCER; CAVITY CANCER; SURGERY; HEAD; CHEMOTHERAPY; RADIATION;
D O I
10.1007/s11864-019-0631-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Opinion statementAt our institution, locally advanced oral cancer is most commonly treated with surgical resection, immediate reconstruction, and adjuvant radiotherapy with or without concurrent systemic therapy depending on final surgical pathologic analysis. There are patients with markedly advanced local or regional disease who unfortunately will have a low probability of cure. We counsel these patients on induction chemotherapy, emphasizing that this is unlikely to result in a smaller volume of surgical resection. In these patients, a good response to induction chemotherapy is more frequently followed by concurrent chemoradiotherapy. We have not been in the practice of commonly recommending definitive chemoradiotherapy for locally advanced oral cancer when upfront surgery is an option. However, as reviewed below, there is a significant rationale for definitive chemoradiotherapy in patients who are surgical candidates, with the hope of good oncologic outcomes, and potential functional organ preservation. The experts who report their experiences in the studies reviewed below provide a strong argument for considering this approach.
引用
收藏
页数:9
相关论文
共 31 条
  • [1] Financial Hardships Experienced by Cancer Survivors: A Systematic Review
    Altice, Cheryl K.
    Banegas, Matthew P.
    Tucker-Seeley, Reginald D.
    Yabroff, K. Robin
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (02):
  • [2] Preoperative chemotherapy in advanced resectable OCSCC: long-term results of a randomized phase III trial
    Bossi, P.
    Lo Vullo, S.
    Guzzo, M.
    Mariani, L.
    Granata, R.
    Orlandi, E.
    Locati, L.
    Scaramellini, G.
    Fallai, C.
    Licitra, L.
    [J]. ANNALS OF ONCOLOGY, 2014, 25 (02) : 462 - 466
  • [3] Burtness B, 2018, EUR SOC MED ONC C OC
  • [4] Cohen E.E. W., 2018, Lancet
  • [5] EFFICACY AND SAFETY OF TREATING T4 ORAL CAVITY TUMORS WITH PRIMARY CHEMORADIOTHERAPY
    Cohen, Ezra E. W.
    Baru, Joshua
    Huo, Dezheng
    Haraf, Daniel J.
    Crowley, Maureen
    Witt, Mary Ellyn
    Blair, Elizabeth A.
    Weichselbaum, Ralph R.
    Rosen, Fred
    Vokes, Everett E.
    Stenson, Kerstin
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2009, 31 (08): : 1013 - 1021
  • [6] Primary chemoradiotherapy for oral cavity squamous cell carcinoma
    Crombie, Anthony K.
    Farah, Camile
    Tripcony, Lee
    Dickie, Graeme
    Batstone, Martin D.
    [J]. ORAL ONCOLOGY, 2012, 48 (10) : 1014 - 1018
  • [7] Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer
    D'Cruz, Anil K.
    Vaish, Richa
    Kapre, Neeti
    Dandekar, Mitali
    Gupta, Sudeep
    Hawaldar, Rohini
    Agarwal, Jai Prakash
    Pantvaidya, Gouri
    Chaukar, Devendra
    Deshmukh, Anuja
    Kane, Shubhada
    Arya, Supreeta
    Ghosh-Laskar, Sarbani
    Chaturvedi, Pankaj
    Pai, Prathamesh
    Nair, Sudhir
    Nair, Deepa
    Badwe, Rajendra
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (06) : 521 - 529
  • [8] Long-term update of the 24954 EORTC phase III trial on larynx preservation
    De Figueiredo, B. Henriques
    Fortpied, C.
    Menis, J.
    Lefebvre, J. L.
    Barzan, L.
    de Raucourt, D.
    Geoffrois, L.
    Giurgea, L.
    Hupperets, P.
    Leemans, C. R.
    Licitra, L.
    Rolland, F.
    Tesselaar, M.
    Vermorken, J. B.
    Gregoire, V.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 65 : 109 - 112
  • [9] Definitive (chemo)radiotherapy is a curative alternative for standard of care in advanced stage squamous cell carcinoma of the oral cavity
    Elbers, Joris B. W.
    Al-Mamgani, Abrahim
    Paping, Danique
    van den Brekel, Michiel W. M.
    Jozwiak, Katarzyna
    de Boer, J. P.
    Karakullukcu, Baris
    Verheij, Marcel
    Zuur, Charlotte L.
    [J]. ORAL ONCOLOGY, 2017, 75 : 163 - 168
  • [10] Definitive chemoradiation for locally-advanced oral cavity cancer: A 20-year experience
    Foster, Corey C.
    Melotek, James M.
    Brisson, Ryan J.
    Seiwert, Tanguy Y.
    Cohen, Ezra E. W.
    Stenson, Kerstin M.
    Blair, Elizabeth A.
    Portugal, Louis
    Gooi, Zhen
    Agrawal, Nishant
    Vokes, Everett E.
    Haraf, Daniel J.
    [J]. ORAL ONCOLOGY, 2018, 80 : 16 - 22